Show simple item record

dc.contributor.authorHart, David S.
dc.date.accessioned2021-10-08T18:54:55Z
dc.date.available2021-10-08T18:54:55Z
dc.date.issued2007-12-31
dc.identifier.urihttp://hdl.handle.net/1808/32011
dc.descriptionThesis (M.S.)--University of Kansas, Pharmaceutical Chemistry, 2007.en_US
dc.description.abstractPoly(ethylene oxide) (PEO)-poly(ester) copolymers are biocompatible, biodegradable diblock polymers that spontaneously form core-shell nanoparticles (i.e. micelles) in water. The hydrophobic polyester core of these micelles can solubilize small, hydrophobic drug molecules that have shown promise in the treatment of cancer and infectious diseases. This core has undergone much development in recent years to improve the stability, drug loading capacity, and release rates of drugs. The PEO shell is well known to increase the circulatory lifetime of micelles with little or no immune response. This thesis will emphasize PEO-poly(e-caprolactone) micelles in order to highlight recent advances in this area.en_US
dc.publisherUniversity of Kansasen_US
dc.rightsThis item is protected by copyright and unless otherwise specified the copyright of this thesis/dissertation is held by the author.en_US
dc.subjectPure sciencesen_US
dc.titlePolyethylene oxide-polyester micelles for drug deliveryen_US
dc.typeThesisen_US
dc.thesis.degreeDisciplinePharmaceutical Chemistry
dc.thesis.degreeLevelM.S.
kusw.bibid6599306
dc.rights.accessrightsopenAccessen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record